HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rapidly progressive Guillain-Barré syndrome following Escherichia coli infection.

Abstract
Guillain-Barré Syndrome (GBS) is a prototype of post-infectious autoimmune disease. A 76-year-old woman was treated for a renal abscess and developed muscle weakness in all four extremities, 18 days after the onset of infection. She was diagnosed with GBS on the basis of acute flaccid paralysis, hyporeflexia, nerve conduction studies (reduced amplitude of compound muscle action potentials), and high titers of IgG antibodies to GM1 and GalNAc-GD1a. GBS rarely occurs after sepsis and this case represents the first report of rapidly progressive GBS following Escherichia coli urosepsis.
AuthorsYuriko Kono, Kazutaka Nishitarumizu, Takuya Higashi, Kei Funakoshi, Masaaki Odaka
JournalInternal medicine (Tokyo, Japan) (Intern Med) Vol. 46 Issue 9 Pg. 589-91 ( 2007) ISSN: 1349-7235 [Electronic] Japan
PMID17473495 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Autoantibodies
  • Gangliosides
  • Immunoglobulin G
  • G(M1) Ganglioside
  • IV(4)-galactosyl-N-acetylganglioside GD1a
Topics
  • Abscess (microbiology)
  • Aged
  • Autoantibodies (blood)
  • Disease Progression
  • Escherichia coli Infections (complications)
  • Female
  • G(M1) Ganglioside (immunology)
  • Gangliosides (immunology)
  • Guillain-Barre Syndrome (diagnosis, etiology, physiopathology, therapy)
  • Humans
  • Immunoglobulin G (blood)
  • Immunosorbent Techniques
  • Immunotherapy (methods)
  • Kidney Diseases (microbiology)
  • Neural Conduction
  • Paraplegia (etiology)
  • Reflex, Abnormal
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: